AEON Biopharma, Inc. Current Liabilities
AEON Biopharma, Inc. (AEON) had Current Liabilities of $7.34 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $7.34M.
- 2026-03-31: Liabilities, Current $6.67M.
- 2025-12-31: Liabilities, Current $6.90M.
- 2025-09-30: Liabilities, Current $8.23M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.34M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $6.67M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $6.90M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $8.23M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $9.13M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $8.64M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $14.15M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $10.73M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $10.43M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $15.96M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $13.05M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $14.18M 10-Q/A · filed 2024-03-29 | |
| 2023-06-30 | $9.46M 10-Q · filed 2023-07-21 | |
| 2023-03-31 | $5.87M 10-Q · filed 2023-05-17 | |
| 2022-12-31 | $82.57M 10-K/A · filed 2024-05-14 | $3.88M 10-K · filed 2023-02-22 |
| 2022-09-30 | $1.35M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $965.78K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $791.84K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $834.59K 10-K/A · filed 2023-04-10 | |
| 2021-09-30 | $223.50K 10-Q/A · filed 2022-03-03 | |
| 2021-06-30 | $206.44K 10-Q/A · filed 2022-03-03 | |
| 2021-03-31 | $467.99K 10-Q/A · filed 2022-03-03 | |
| 2020-12-31 | $59.59K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |